In line with our previous study showing an enhanced immunosuppressive microenvironment in higher grade gliomas [23], patients with SD were those with lower grade gliomas and a GBM case with high mutational load, low presence of immune suppressive macrophages, high number of CD8+ T cells and high expression of MHC class I molecules. The gene discussed is CD8A; the disease is glioblastoma.